Xellia Pharmaceuticals

Xellia Pharmaceuticals (Denmark) holds 19 active US FDA Type II Drug Master Files and 4 inactive, has DMF or CEP filings on record for 13 active ingredients, holds 0 active Type IV (excipient) Drug Master Files and is linked to 3 FDA-registered manufacturing sites. 3 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Xellia Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/xellia-pharmaceuticals

Overview

Xellia Pharmaceuticals is a pharmaceutical company headquartered in Copenhagen, Denmark.

Core services & business areas

Anti-infective ProductsFermentationLyophilizationInjection Manufacturing

Active ingredients with DMF or CEP filings

Substances for which Xellia Pharmaceuticals holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Xellia Pharmaceuticals holds 19 active (23 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • DALBAVANCIN HYDROCHLORIDEActive2024-03-27
  • VANCOMYCIN WET BASE, NON-STERILEActive2017-07-20
  • BACITRACIN ZINC, STERILEActive2014-06-20
  • DAPTOMYCIN NON-STERILEActive2013-07-16
  • DAPTOMYCINActive2012-12-21
  • VANCOMYCIN HYDROCHLORIDEActive2007-06-11
  • GRAMICIDIN, USPActive2004-07-12
  • TOBRAMYCIN SULPHATE, USP STERILE BULKActive2001-09-17
  • TOBRAMYCIN SULPHATE, NON-STERILE BULKActive2000-09-12
  • POLYMYXIN B SULFATEActive1999-06-10
  • VANCOMYCIN HYDROCHLORIDEActive1998-09-01
  • BACITRACIN ZINC USP NON-STERILEActive1998-09-01
  • COLISTIMETHATE SODIUM USPActive1998-09-01
  • VANCOMYCIN HYDROCHLORIDEActive1998-09-01
  • COLISTIN SULFATEActive1998-09-01
  • BACITRACIN USP NON-STERILEActive1998-09-01
  • AMPHOTERICIN BActive1998-09-01
  • BACITRACIN STERILE USPActive1998-09-01
  • POLYMYXIN B SULFATE, STERILEActive1998-09-01
  • CASPOFUNGIN (ACETATE)Inactive2013-06-14
  • MUPIROCIN USP, NON-STERILEInactive2010-05-25
  • TOBRAMYCIN SULFATE, USP STERILEInactive2003-08-20
  • BACITRACIN ZINC STERILE USPInactive1998-09-01

Excipient Drug Master Files

Xellia Pharmaceuticals holds 0 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • N-ACETYL-D-ALANINEInactive2017-09-21

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Xellia Pharmaceuticals, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

3 FDA enforcement records linked to this company.

  • 4832018-05-08

    Procedures not in writing, fully followed

  • 4832018-05-08

    Investigations of discrepancies, failures

  • 4832018-05-08

    Procedures for sterile drug products

For suppliers

Is this Xellia Pharmaceuticals?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.